TGM2 and hepatocellular carcinoma: The present TCGA cohort study on the TGF-β1/TG2 mutual activation of HCC suggests that TGF-β1 is a poor prognostic factor for early-stage survival, as is TG2 for late-stage survival (Figure 5D).